Singapore markets open in 7 hours 18 minutes

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
22.85-0.72 (-3.07%)
As of 01:41PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 2.88B
Enterprise value 3.10B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.56
Price/book (mrq)42.24
Enterprise value/revenue 5.14
Enterprise value/EBITDA -4.62

Trading information

Stock price history

Beta (5Y monthly) 0.92
52-week change 3-17.62%
S&P500 52-week change 329.31%
52-week high 341.06
52-week low 315.81
50-day moving average 319.21
200-day moving average 324.99

Share statistics

Avg vol (3-month) 32.23M
Avg vol (10-day) 33.22M
Shares outstanding 5122.37M
Implied shares outstanding 6122.37M
Float 8109.82M
% held by insiders 14.53%
% held by institutions 195.53%
Shares short (30 Apr 2024) 410.16M
Short ratio (30 Apr 2024) 44.75
Short % of float (30 Apr 2024) 48.69%
Short % of shares outstanding (30 Apr 2024) 48.34%
Shares short (prior month 28 Mar 2024) 47.64M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -76.34%
Operating margin (ttm)-59.16%

Management effectiveness

Return on assets (ttm)-17.29%
Return on equity (ttm)-3,883.89%

Income statement

Revenue (ttm)603.72M
Revenue per share (ttm)5.17
Quarterly revenue growth (yoy)30.90%
Gross profit (ttm)N/A
EBITDA -401.6M
Net income avi to common (ttm)-460.9M
Diluted EPS (ttm)-3.92
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.03B
Total cash per share (mrq)8.41
Total debt (mrq)1.35B
Total debt/equity (mrq)1,973.31%
Current ratio (mrq)5.95
Book value per share (mrq)0.56

Cash flow statement

Operating cash flow (ttm)-280.82M
Levered free cash flow (ttm)-258.75M